Education
About Us
Working with TipRanks
Follow Us
China Sxt Pharmaceuticals (SXTC)
:SXTC
SXTC Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.95 - $10.24
Previous CloseN/A
Volume317.99K
Average Volume (3M)68.01K
Market Cap
$187.96M
Enterprise Value$184.11M
Total Cash (Recent Filing)$12.07M
Total Debt (Recent Filing)$2.65M
Price to Earnings (P/E)<0.1
Beta0.68
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)2.73
Shares Outstanding116,027,756
10 Day Avg. Volume69,246
30 Day Avg. Volume68,011
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.15
Price to Sales (P/S)0.00
P/FCF Ratio-142.09
Enterprise Value/Market Cap0.98
Enterprise Value/Revenue17.63
Enterprise Value/Gross Profit309.23
Enterprise Value/Ebitda-5.80
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
China SXT Pharmaceuticals News
PremiumCompany Announcements
China SXT Pharmaceuticals Issues 90 Million Shares Following Warrant Exercise
PremiumCompany Announcements
China SXT Pharmaceuticals Completes Share Sale Agreement
PremiumMarket News
3 Penny Stocks to Watch Now, 4/22/25
PremiumCompany Announcements
China SXT Pharmaceuticals Optimizes Capital Structure with Warrant Exchange
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
―
Mutual Funds
0.44% Other Institutional Investors
100.00% Public Companies and
Individual Investors
SXTC FAQ
What was China Sxt Pharmaceuticals’s price range in the past 12 months?
China Sxt Pharmaceuticals lowest stock price was $0.95 and its highest was $10.24 in the past 12 months.
What is China Sxt Pharmaceuticals’s market cap?
China Sxt Pharmaceuticals’s market cap is $187.96M.
When is China Sxt Pharmaceuticals’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were China Sxt Pharmaceuticals’s earnings last quarter?
Currently, no data Available
Is China Sxt Pharmaceuticals overvalued?
According to Wall Street analysts China Sxt Pharmaceuticals’s price is currently Overvalued.
Does China Sxt Pharmaceuticals pay dividends?
China Sxt Pharmaceuticals does not currently pay dividends.
What is China Sxt Pharmaceuticals’s EPS estimate?
China Sxt Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does China Sxt Pharmaceuticals have?
China Sxt Pharmaceuticals has 116,027,756 shares outstanding.
What happened to China Sxt Pharmaceuticals’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of China Sxt Pharmaceuticals?
Currently, no hedge funds are holding shares in SXTC
China SXT Pharmaceuticals Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Crowd Wisdom
Negative
Last 7 Days ▼ 1.1%
Last 30 Days ▲ 0.3%
Last 30 Days ▲ 0.3%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-82.23%
12-Months-Change
Fundamentals
Return on Equity
57.63%
Trailing 12-Months
Asset Growth
112.49%
Trailing 12-Months
Company Description
China Sxt Pharmaceuticals
China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine piece tablets (TCMP) in China. The company offers advanced, fine, and regular TCMP products, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. As of March 31, 2022, it had an end-customer base of 68 pharmaceutical companies, 14 chain pharmacies, and 20 hospitals in 10 provinces and municipalities in China. The company was founded in 2005 and is headquartered in Taizhou, China.